Literature DB >> 18566959

Neural commitment of embryonic stem cells: molecules, pathways and potential for cell therapy.

D M Suter1, K-H Krause.   

Abstract

The study of neuronal differentiation of embryonic stem cells has raised major interest over recent years. It allows a better understanding of fundamental aspects of neurogenesis and, at the same time, the generation of neurons as tools for various applications ranging from drug testing to cell therapy and regenerative medicine. Since the first report of human embryonic stem (ES) cells derivation, many studies have shown the possibility of directing their differentiation towards neurons. However, there are still many challenges ahead, including gaining a better understanding of the mechanisms involved and developing techniques to allow the generation of homogeneous neuronal and glial subtypes. We review the current state of knowledge of embryonic neurogenesis which has been acquired from animal models and discuss its translation into in vitro strategies of neuronal differentiation of ES cells. We also highlight several aspects of current protocols which need to be optimized to generate high-quality embryonic stem cell-derived neuronal precursors suitable for clinical applications. Finally, we discuss the potential of embryonic stem cell-derived neurons for cell replacement therapy in several central nervous system diseases. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18566959     DOI: 10.1002/path.2380

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

Review 1.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

Review 2.  Generating spinal motor neuron diversity: a long quest for neuronal identity.

Authors:  Cédric Francius; Frédéric Clotman
Journal:  Cell Mol Life Sci       Date:  2013-06-14       Impact factor: 9.261

3.  Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing.

Authors:  Jia Qian Wu; Lukas Habegger; Parinya Noisa; Anna Szekely; Caihong Qiu; Stephen Hutchison; Debasish Raha; Michael Egholm; Haifan Lin; Sherman Weissman; Wei Cui; Mark Gerstein; Michael Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

4.  Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2.

Authors:  Andrew B Sharabi; Sung-Hyung Lee; Margaret A Goodell; Xue F Huang; Si-Yi Chen
Journal:  Cloning Stem Cells       Date:  2009-12

5.  Human pluripotent stem cells: applications and challenges in neurological diseases.

Authors:  Youssef Hibaoui; Anis Feki
Journal:  Front Physiol       Date:  2012-07-20       Impact factor: 4.566

Review 6.  Human umbilical cord blood stem cells: rational for use as a neuroprotectant in ischemic brain disease.

Authors:  Hadar Arien-Zakay; Shimon Lecht; Arnon Nagler; Philip Lazarovici
Journal:  Int J Mol Sci       Date:  2010-09-21       Impact factor: 5.923

Review 7.  Neural tissue engineering using embryonic and induced pluripotent stem cells.

Authors:  Stephanie M Willerth
Journal:  Stem Cell Res Ther       Date:  2011-04-15       Impact factor: 6.832

8.  Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues.

Authors:  Y Martinez; M Dubois-Dauphin; K-H Krause
Journal:  Front Physiol       Date:  2012-03-19       Impact factor: 4.566

9.  Phenazopyridine induces and synchronizes neuronal differentiation of embryonic stem cells.

Authors:  David M Suter; Olivier Preynat-Seauve; Diderik Tirefort; Anis Feki; Karl-Heinz Krause
Journal:  J Cell Mol Med       Date:  2009-09       Impact factor: 5.310

10.  Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells.

Authors:  Olivier Preynat-Seauve; Casimir de Rham; Diderik Tirefort; Sylvie Ferrari-Lacraz; Karl-Heinz Krause; Jean Villard
Journal:  J Cell Mol Med       Date:  2009-03-13       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.